Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $3.1B Activated in VL: True Average Daily Range Avg Daily Range: $1.53 | 3.47% Avg Daily Range (30 D): $0.93 | 3.77% Avg Daily Range (90 D): $0.64 | 3.04% Institutional Daily Volume Avg Daily Volume: .96M Avg Daily Volume (30 D): 2.2M Avg Daily Volume (90 D): 2.2M Trade Size Avg Trade Size (Sh.): 59 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 67 Institutional Trades Total Inst.Trades: 3,154 Avg Inst. Trade: $3.15M Avg Inst. Trade (30 D): $3.4M Avg Inst. Trade (90 D): $3.08M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.88M Avg Closing Trade (30 D): $6.46M Avg Closing Trade (90 D): $5.07M Avg Closing Volume: 138.74K     News Jun 28, 2025 @ 1:10 PM 10 Under-the-Radar Healthcare Stocks With Incredib... Source: Dan Victor Jun 17, 2025 @ 2:07 PM Editas Medicine Is Great. Here's Why You Shouldn't... Source: Dan Victor May 29, 2025 @ 8:01 PM Beam Therapeutics Announces U.S. FDA Orphan Drug D... Source: N/A May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.5 $-1 $-1.24 Diluted EPS $-4.5 $-1 $-1.24 Revenue $ 60.27M $ 8.47M $ 7.47M Gross Profit $ $ $ Net Income / Loss $ -398.58M $ -102.29M $ -109.27M Operating Income / Loss $ -445.98M $ -120.15M $ -119.29M Cost of Revenue $ $ $ Net Cash Flow $ -10.15M $ -245.75M $ 244.41M PE Ratio